retatrutide dosing phase 2 trial dose: the complete guide to protocols, titration, and results Phase 2 Trial of Retatrutide

10.1038/s41580-025-00826-3 Nat

Less Nausea: Many current weight loss drugs, particularly GLP-1 receptor agonists, are associated with gastrointestinal side effects such as nausea, vomiting, and diarrhea

One must have a BMI of 30 or above, or a BMI of at least 27 or above with a weight-related health condition like high blood pressure, diabetes, or high cholesterol

It helps regulate blood sugar, slows stomach emptying and contributes to feelings of fullness

We offer a full spectrum of services and, depending on your needs, may recommend nutritional and physical activity counseling, psychological and lifestyle counseling, medications, endoscopic bariatric procedures and/or surgery

Verify hospital privileges and multidisciplinary care.